Literature DB >> 17904504

Health-related quality of life for children with chronic kidney disease.

Stuart L Goldstein1, Arlene C Gerson, Susan Furth.   

Abstract

Medical care advancements for children with chronic kidney disease (CKD) receiving hemodialysis, peritoneal dialysis, or with a kidney transplant have resulted in relatively improved long-term patient survival compared with adult patients with CKD. Optimal care for the pediatric patient with CKD requires attention not only to medical management but also the psychosocial and developmental factors that will either ensure or prevent a pediatric patient's successful transition into adulthood. We review the range of issues that impact pediatric CKD patient health-related quality of life (HRQOL), the history of pediatric CKD patient HRQOL investigation, and the instruments currently available to assess HRQOL.

Entities:  

Mesh:

Year:  2007        PMID: 17904504     DOI: 10.1053/j.ackd.2007.07.006

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  10 in total

1.  Psychological impact of chronic kidney disease among children and adolescents: Not rare and not benign.

Authors:  Farahnak Assadi
Journal:  J Nephropathol       Date:  2013-01-01

2.  Health-related quality of life functioning over a 2-year period in children with end-stage renal disease.

Authors:  Shari K Neul; Charles G Minard; Helen Currier; Stuart L Goldstein
Journal:  Pediatr Nephrol       Date:  2012-09-28       Impact factor: 3.714

3.  Behavioral disorders and low quality of life in children and adolescents with chronic kidney disease.

Authors:  Renata C Marciano; Cristina M Bouissou Soares; José Silvério S Diniz; Eleonora M Lima; Jose Maria P Silva; Monica R Canhestro; Andrea Gazzinelli; Carla Cristina D Melo; Cristiane S Dias; Ana Cristina Simões e Silva; Humberto Correa; Eduardo A Oliveira
Journal:  Pediatr Nephrol       Date:  2010-11-26       Impact factor: 3.714

4.  Cost-related immunosuppressive medication nonadherence among kidney transplant recipients.

Authors:  Roger W Evans; William H Applegate; David M Briscoe; David J Cohen; Christopher C Rorick; Barbara T Murphy; Joren C Madsen
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-16       Impact factor: 8.237

5.  Health-related quality of life of children and adolescents with CKD stages 4-5 and their caregivers.

Authors:  Marcos Lopes; Alexandre Ferraro; Vera H Koch
Journal:  Pediatr Nephrol       Date:  2014-02-28       Impact factor: 3.714

6.  Quality of life of adolescents with end-stage renal disease and kidney transplant.

Authors:  Isolina Riaño-Galán; Serafín Málaga; Luis Rajmil; Gema Ariceta; Mercedes Navarro; Cesar Loris; Alfredo Vallo
Journal:  Pediatr Nephrol       Date:  2009-05-28       Impact factor: 3.714

7.  Reliability of generic quality-of-life instruments in assessing health-related quality of life among children and adolescents with idiopathic nephrotic syndrome: a systematic review.

Authors:  Ann E Aronu; Samuel N Uwaezuoke; Uzoamaka V Muoneke
Journal:  Health Qual Life Outcomes       Date:  2021-05-12       Impact factor: 3.186

8.  Low serum levels of vitamin D are associated with anxiety in children and adolescents with dialysis.

Authors:  Bin Han; Fu-Xiang Zhu; Hai-Feng Yu; Si Liu; Jun-Liang Zhou
Journal:  Sci Rep       Date:  2018-04-13       Impact factor: 4.379

9.  Associations between lower urinary tract dysfunction and health-related quality of life in children with chronic kidney disease.

Authors:  Helena Öborn; Lena Wettergren; Maria Herthelius; Ulla Forinder
Journal:  Acta Paediatr       Date:  2016-05-27       Impact factor: 2.299

10.  Children on dialysis as well as renal transplanted children report severely impaired health-related quality of life.

Authors:  Anouck Splinter; Lidwien A Tjaden; Lotte Haverman; Brigitte Adams; Laure Collard; Karlien Cransberg; Maria van Dyck; Koen J Van Hoeck; Bernd Hoppe; Linda Koster-Kamphuis; Marc R Lilien; Ann Raes; Christina Taylan; Martha A Grootenhuis; Jaap W Groothoff
Journal:  Qual Life Res       Date:  2018-01-27       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.